By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

INSYS Therapeutics 

10220 South 51st Street
Suite 2
Phoenix  Arizona  85044  U.S.A.
Phone: 602-910-2617 Fax: 602-910-2627


SEARCH JOBS








Company News
INSYS Therapeutics Reports Fourth Quarter And Year End 2014 Results 3/3/2015 9:55:13 AM
INSYS Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA For The Treatment Of Dravet Syndrome 2/27/2015 10:56:51 AM
INSYS Therapeutics In-Licenses Novel Mast Cell Therapy For Chronic Pelvic Pain 2/24/2015 12:36:08 PM
INSYS Therapeutics To Report Fourth Quarter And Year-End 2014 Results 2/19/2015 12:04:59 PM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Liposomal Encapsulated Paclitaxel For The Treatment Of Ovarian Cancer 1/27/2015 11:17:49 AM
INSYS Therapeutics To Initiate Five Phase 3 Clinical Trials In 2015 1/13/2015 12:28:23 PM
INSYS Therapeutics To Present At 33rd Annual J.P. Morgan Healthcare Conference 1/5/2015 9:09:11 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Liposome Entrapped Paclitaxel As A Potential Treatment For Gastric Cancer 12/10/2014 11:21:01 AM
Parallel Comparison Analyses Confirm That INSYS Therapeutics' Synthetic CBD Is Identical In Chemical Structure To Plant-Derived CBD 12/4/2014 11:51:56 AM
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia 11/24/2014 9:45:00 AM
1234567
//-->